
Loading, please wait...

Loading, please wait...

Maintaining geriatric medication appropriateness is a cornerstone of safe clinical practice for the rapidly aging global population. Recent data from the German National Cohort (NAKO) reveals that nearly 26% of older adults encounter potentially inappropriate medication (PIM). Furthermore, medication underuse and overuse remain strikingly common, affecting 19.1% and 23.6% of participants, respectively. These findings underscore the urgent need for systematic medication reviews to mitigate preventable drug-related harms and optimize therapeutic outcomes.
The NAKO study identifies several chronic conditions as strong predictors of inappropriate prescribing. Specifically, Parkinson's disease showed a 16.2-fold increase in the odds of PIM use. Additionally, arterial hypertension and epilepsy significantly raised the risk of inappropriate therapy. Consequently, clinicians should prioritize patients with these complex comorbidities for comprehensive pharmacological assessments. For instance, physicians must regularly evaluate whether the benefits of a prescribed drug still outweigh the risks in the context of changing aging physiology.
Besides PIM use, the study highlighted significant gaps in preventive care, such as low vaccination rates for pneumococcal and influenza viruses. This trend is also evident in the Indian healthcare landscape, where polypharmacy rates often exceed 70% in tertiary care settings. Therefore, implementing standardized screening tools like the Fit fOR The Aged (FORTA) or Beers Criteria is essential for every practice. Because multimorbidity often leads to fragmented care, a multidisciplinary approach involving geriatricians and pharmacists is vital for ensuring medication safety. Moreover, identifying people with specific characteristics helps clinicians prioritize those who would benefit the most from intensive medication reviews.
According to recent cohort data, osteoporosis, atrial fibrillation, and Parkinson\'s disease are particularly associated with underuse. Therefore, clinicians must ensure that these high-risk patients receive evidence-based treatments to prevent secondary complications like fractures and strokes.
Regular medication reviews remain the most effective tool for identifying PIMs and overuse. Consequently, physicians should use validated screening lists to prune unnecessary drugs and address untreated conditions during every scheduled follow-up visit.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


New data from the German National Cohort highlights high rates of inappropriate medication use in older adults, emphasizing the need for medication reviews....
6 months ago

Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today

A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today